We are live on ! Find out more
QGENF

QIAGEN NV
QGENF

Delisted

QGENF was delisted on the 14th of February, 2005.

158 hedge funds and large institutions have $3.19B invested in QIAGEN NV in 2014 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 47 increasing their positions, 65 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,339% more call options, than puts

Call options by funds: $16.1M | Put options by funds: $1.12M

40% more capital invested

Capital invested by funds: $2.27B → $3.19B (+$918M)

5% less funds holding

Funds holding: 166158 (-8)

27% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 30

28% less repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 65

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
158
Holders Change
-8
Holders Change %
-4.82%
% of All Funds
4.54%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
22
Increased
47
Reduced
65
Closed
30
Calls
$16.1M
Puts
$1.12M
Net Calls
+$15M
Net Calls Change
+$14.4M
Name Holding Trade Value Shares
Change
Change in
Stake
DekaBank Deutsche Girozentrale
26
DekaBank Deutsche Girozentrale
Germany
$23.6M -$3.75M -153,323 -14%
Flossbach Von Storch
27
Flossbach Von Storch
Germany
$21.8M +$21.8M +939,662 New
JP Morgan Chase
28
JP Morgan Chase
New York
$21.5M +$20.4M +834,587 +1,916%
GIM
29
Granahan Investment Management
Massachusetts
$20.2M
Goldman Sachs
30
Goldman Sachs
New York
$20M +$12.7M +517,977 +173%
VanEck Associates
31
VanEck Associates
New York
$19.5M -$3.56M -145,663 -15%
O
32
OrbiMed
New York
$19.1M +$19.1M +781,400 New
CA
33
Commerzbank Aktiengesellschaft
Germany
$18.2M -$7.85M -321,077 -30%
O
34
OppenheimerFunds
New York
$16.5M
TCIM
35
TIAA CREF Investment Management
New York
$16.1M -$137K -5,621 -0.8%
VAM
36
Visium Asset Management
New York
$15.8M +$8.72M +356,557 +124%
HSBC Holdings
37
HSBC Holdings
United Kingdom
$13.9M -$432K -17,837 -3%
Bank of Montreal
38
Bank of Montreal
Ontario, Canada
$13.2M +$13.2M +541,730 New
Northern Trust
39
Northern Trust
Illinois
$12.8M +$994K +40,643 +8%
Barclays
40
Barclays
United Kingdom
$12.2M -$6.11M -254,688 -33%
Adage Capital Partners
41
Adage Capital Partners
Massachusetts
$11M -$5.5M -225,000 -33%
Axa
42
Axa
France
$10.6M +$419K +17,134 +4%
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$10.4M +$12.2K +500 +0.1%
FCM
44
Frontier Capital Management
Massachusetts
$10.4M -$609K -24,920 -6%
BCM
45
Brown Capital Management
Maryland
$9.34M +$9.34M +381,985 New
Renaissance Technologies
46
Renaissance Technologies
New York
$9.1M -$16M -656,319 -64%
TM
47
Tikvah Management
North Carolina
$9.03M
GC
48
Guggenheim Capital
Illinois
$8.21M -$2.66M -108,791 -24%
Vanguard Group
49
Vanguard Group
Pennsylvania
$7.77M +$518K +21,186 +7%
State Board of Administration of Florida Retirement System
50
State Board of Administration of Florida Retirement System
Florida
$7.73M -$13K -532 -0.2%

QGENF Hedge Fund Activity: Q2 2014 in Review

158 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in QIAGEN NV (QGENF) for Q2 2014, worth a combined $3.19B — up 40% from $2.27B a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of QGENF and 22 opened new positions — a net loss of 8 holders — while 65 trimmed existing stakes and 47 added.

The largest buyer was Franklin Resources, opening a new position worth an estimated $383M. The largest seller was Manning & Napier Advisors, cutting an estimated $52.7M.

  • 158 institutional investors held QIAGEN NV (QGENF) as of Q2 2014, down from 166 in Q1 2014.
  • Funds reported $3.19B of QIAGEN NV stock for Q2 2014, up 40% quarter-over-quarter.
  • 22 funds opened new QIAGEN NV positions in Q2 2014 and 30 closed out, a net change of -8 holders.
  • The largest QIAGEN NV buyer in Q2 2014 was Franklin Resources, an estimated $383M added.
  • The largest QIAGEN NV seller in Q2 2014 was Manning & Napier Advisors, an estimated $52.7M sold.

Based on aggregated 13F filings for Q2 2014.